Markets.com Logo
markets.com

EQTL

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.2524$
  • Previous Close
    1.2524$
  • 52 Week Change
    1.10$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.4$ - 1.5$
  • Dividend Per Share
    --
  • Market cap
    1 904 K$
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

EQTL.US represents Equillium, Inc., a biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders. They are working on a selective co-stimulation blocker that targets the CD6-ALCAM pathway. The .US suffix simply denotes that this is the Equillium stock listed on a United States stock exchange.
markets.com
Coinbase Stock Forecast 2026–2030: Can COIN Recover as Bitcoin Nears $80,000?

Coinbase Stock Forecast 2026–2030: Can COIN Recover as Bitcoin Nears $80,000?

Julian Parker|--
Samsung Stock Forecast: Can AI Memory Demand Offset the Latest Sell-Off?

Samsung Stock Forecast: Can AI Memory Demand Offset the Latest Sell-Off?

Julian Parker|--
Robinhood Stock Forecast 2026–2030: Can Bitcoin’s Rally Drive HOOD Higher?

Robinhood Stock Forecast 2026–2030: Can Bitcoin’s Rally Drive HOOD Higher?

Julian Parker|--
Copper Price Forecast 2026, 2027 and 2030: Can Prices Hold Above $14,000?

Copper Price Forecast 2026, 2027 and 2030: Can Prices Hold Above $14,000?

Daniel Carter|--
Marvell Stock Forecast 2026 and 2030: Can MRVL Reach $300?

Marvell Stock Forecast 2026 and 2030: Can MRVL Reach $300?

Daniel Carter|--
Lumentum Holdings (LITE) Stock Forecast 2026–2030: Can AI Optics Sustain the Rally?

Lumentum Holdings (LITE) Stock Forecast 2026–2030: Can AI Optics Sustain the Rally?

Julian Parker|--
IBM Stock Forecast 2026–2030: Is IBM a Buy After Its 25% Q2 Drop?

IBM Stock Forecast 2026–2030: Is IBM a Buy After Its 25% Q2 Drop?

Julian Parker|--

Factors

Company Performance: Earnings reports, revenue growth, and profit margins significantly influence investor confidence and stock valuation. Biotech Industry Trends: Overall sentiment towards the biotechnology sector, driven by regulatory changes, clinical trial successes, and competitor activities, impacts EQTL.US. Clinical Trial Results: Positive or negative outcomes from Equillium's clinical trials for its drug candidates directly affect stock price due to potential revenue implications. FDA Approval: Receipt of FDA approval for Equillium's drugs greatly enhances commercial prospects, leading to stock price appreciation. Conversely, rejection can cause a price decline. Market Sentiment: General investor optimism or pessimism regarding market conditions, influenced by macroeconomic factors like interest rates and inflation, plays a role. Partnerships & Collaborations: Announcements of partnerships with other pharmaceutical companies or research institutions can boost investor confidence and increase stock value.

People Also Watch

Latest news

BTC Breaks $80K as ETF Inflows and Short Squeeze Fuel Rally

BTC Breaks $80K as ETF Inflows and Short Squeeze Fuel Rally

Julian Parker|--
Gold Price Today, August 25: XAU/USD Nears $4,700 as Safe-Haven Rally Accelerates

Gold Price Today, August 25: XAU/USD Nears $4,700 as Safe-Haven Rally Accelerates

Julian Parker|--
GBP/USD Today: Pound Holds Near Six-Month High as 1.3660 Breakout Looms

GBP/USD Today: Pound Holds Near Six-Month High as 1.3660 Breakout Looms

Julian Parker|--

Latest Education Articles

XAU/USD Trading Hours in Dubai: When Does the Gold Market Open?

XAU/USD Trading Hours in Dubai: When Does the Gold Market Open?

Daniel Carter|--
How to Trade Gold CFDs: A Beginner’s Guide to XAU/USD Trading

How to Trade Gold CFDs: A Beginner’s Guide to XAU/USD Trading

Daniel Carter|--
How to Read a Forex Chart: A Beginner’s Guide to Candlesticks and Trends

How to Read a Forex Chart: A Beginner’s Guide to Candlesticks and Trends

Daniel Carter|--
Recommended Topics
markets.com